123 related articles for article (PubMed ID: 2661789)
1. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
Marshall G; Kerr S; Vowels M; O'Gorman-Hughes D; White L
J Pediatr; 1989 Jul; 115(1):156-60. PubMed ID: 2661789
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
Stephens SH; Silvey VL; Wheeler RH
Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
[TBL] [Abstract][Full Text] [Related]
5. The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial.
Richards PD; Flaum MA; Bateman M; Kardinal CG
Cancer; 1986 Aug; 58(4):959-62. PubMed ID: 3521843
[TBL] [Abstract][Full Text] [Related]
6. Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
Relling MV; Mulhern RK; Fairclough D; Baker D; Pui CH
J Pediatr; 1993 Nov; 123(5):811-6. PubMed ID: 8229497
[TBL] [Abstract][Full Text] [Related]
7. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
[TBL] [Abstract][Full Text] [Related]
8. Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
Fanning J; Hilgers RD
Obstet Gynecol; 1994 Apr; 83(4):601-4. PubMed ID: 8134073
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
Malik IA; Khan WA; Qazilbash M; Ata E; Butt A; Khan MA
Am J Clin Oncol; 1995 Apr; 18(2):170-5. PubMed ID: 7900711
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
11. High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
Herrstedt J; Hannibal J; Hallas J; Andersen E; Laursen LC; Hansen M
Ann Oncol; 1991 Mar; 2(3):223-7. PubMed ID: 2043493
[TBL] [Abstract][Full Text] [Related]
12. Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
Gordon CJ; Pazdur R; Ziccarelli A; Cummings G; Al-Sarraf M
Cancer; 1989 Feb; 63(3):578-82. PubMed ID: 2912533
[TBL] [Abstract][Full Text] [Related]
13. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J
Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.
Palmer MC; Colls BM
Cancer Chemother Pharmacol; 1987; 19(4):331-4. PubMed ID: 3297375
[TBL] [Abstract][Full Text] [Related]
15. Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
Pollera CF; Nardi M; Marolla P; Pinnaró P; Terzoli E; Giannarelli D
Am J Clin Oncol; 1989 Dec; 12(6):524-9. PubMed ID: 2589233
[TBL] [Abstract][Full Text] [Related]
16. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S
Oncology; 1989; 46(3):150-4. PubMed ID: 2654792
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.
Gagen M; Gochnour D; Young D; Gaginella T; Neidhart J
J Clin Oncol; 1984 Jun; 2(6):696-701. PubMed ID: 6374059
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy.
Ibrahim EM; Al-Idrissi HY; Ibrahim A; Absood G; Al-Dossary E; Al-Jammaa A; Al-Ethan S; Eliopoulos A
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):283-8. PubMed ID: 3519233
[TBL] [Abstract][Full Text] [Related]
20. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
